Selgian
Active substance
ATC code
Species
Dogs.
Indications
1. Treatment of behavioural disorders of purely emotional origin: depression, anxiety.
2. In association with behaviour therapy, treatment of signs of emotional origin observed in behavioural conditions such as over activity, separation problems, generalised phobia and unsociable behaviour.
Emotional disorders are characterised by a modification of feeding, drinking, auto-stimulatory behaviour, sleep, exploratory behaviour, aggression related to fear and/or irritation, social behaviour and somatic disorders (tachycardia, emotional micturition)
Dose to be administered and administration route
Oral route: 0.5 mg/kg/day of (–) selegiline hydrochloride in a single administration.
|
Dog weight in kg |
Number of tablets |
|
|
≥1.5 < 3 |
¼ |
|
|
≥3 < 5 |
½ |
|
|
≥5 < 7 |
¾ |
|
|
≥7 < 9 |
1 |
|
|
≥9 < 11 |
1 ¼ |
|
|
≥11 < 13 |
1 ½ |
|
|
≥13 < 15 |
1 ¾ |
|
|
≥15 < 17 |
2 |
|
For dogs weighing more than 17 kg, the use of Selgian® 10 mg is advisable in order to reduce the number of tablets to be administered.
The treatment should be continued until the clinical condition is stable.
The minimum treatment period recommended is 2 months, based on the clinical trials results:
• The treatment period was 2 to 3 months for 20 % of the dogs
• The treatment period was 4 to 5 months for 50 % of the dogs
• The treatment period was 6 to 7 months for 20 % of the dogs
• The treatment period was > 7 months for 10 % of the dogs
The treatment can be stopped suddenly without gradual dose reductions.
Adverse reactions
Trials have shown that some dominant dogs, with behavioural disorders but no signs of aggression, may become aggressive after treatment. Those previously showing aggression may have this enhanced. Appropriate training is essential in such cases.
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 14966/4000 |
| EAN | 3411110007815 |
